Rockbridge Investment Management’s Novartis NVS Stock Holding History

Rockbridge Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,165	Closed	-$118K	–	458
2023 Q4	$118K	Buy	+1,165	New	+$112K	0.02%	159
2022 Q3	–	Sell	-235	Closed	-$19.9K	–	436
2022 Q2	$19.9K	Hold	235	–	–	﹤0.01%	305
2022 Q1	$20.6K	Hold	235	–	–	﹤0.01%	414
2021 Q4	$21K	Hold	235	–	–	﹤0.01%	478
2021 Q3	$19K	Sell	235 -131	-36%	-$11.8K	﹤0.01%	455
2021 Q2	$33K	Hold	366	–	–	0.01%	370
2021 Q1	$31K	Buy	366 +80	+28%	+$7.18K	0.01%	353
2020 Q4	$27K	Hold	286	–	–	0.01%	367
2020 Q3	$25K	Hold	286	–	–	0.01%	351
2020 Q2	$25K	Buy	+286	New	+$24.7K	0.01%	310

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockbridge Investment Management's NVS Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Novartis (NVS) in Q1 2024, closing a stake of 1,165 shares — an estimated $118K sold.

Rockbridge Investment Management first reported a position in NVS in Q2 2020 and held it in 10 quarters. The position peaked at $118K in Q4 2023. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

Rockbridge Investment Management reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 1,165 Novartis shares in Q1 2024, an estimated $118K.
Rockbridge Investment Management first reported a position in Novartis in Q2 2020 and held it in 10 quarters.
Rockbridge Investment Management's Novartis position peaked at $118K in Q4 2023.
1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.